Jozef Nauta

Statistics in Clinical and Observational Vaccine Studies

• Broschiertes Buch

Produktbeschreibung

This book offers an overview of the statistical methods used in clinical and observational vaccine studies. Pursuing a practical rather than theoretical approach, it presents a range of real-world examples with SAS codes, making the application of the methods straightforward.

This revised edition has been significantly expanded to reflect the current interest in this area. It opens with two introductory chapters on the immunology of vaccines to provide readers with the necessary background knowledge. It then continues with an in-depth exploration of the analysis of immunogenicity data. Discussed are, amongst others, maximum likelihood estimation for censored antibody titers, ANCOVA for antibody values, analysis of data of equivalence, and non-inferiority immunogenicity studies. Other topics covered include fitting protection curves to data from vaccine efficacy studies, and the analysis of vaccine safety data.

In addition, the book features four new chapters onvaccine field studies: an introductory one, one on randomized vaccine efficacy studies, one on observational vaccine effectiveness studies, and one on the meta-analysis of vaccine efficacy studies.

The book offers useful insights for statisticians and epidemiologists working in the pharmaceutical industry or at vaccines institutes, as well as graduate students interested in pharmaceutical statistics.

Produktdetails

• Springer Series in Pharmaceutical Statistics
• Verlag: Springer / Springer International Publishing / Springer, Berlin
• Artikelnr. des Verlages: 978-3-030-37695-6
• 2. Aufl.
• Seitenzahl: 256
• Erscheinungstermin: 15. März 2021
• Englisch
• Abmessung: 235mm x 155mm x 15mm
• Gewicht: 394g
• ISBN-13: 9783030376956
• ISBN-10: 3030376958
• Artikelnr.: 61198512

Autorenporträt

Jozef Nauta is a principal statistician, with more than 25 years of experience in the pharmaceutical industry, and with special interest in the development of influenza vaccines. During his career he has published numerous journal articles on statistics and vaccines. He currently participates in Development of Robust and Innovative Vaccine Effectiveness (DRIVE), a public private partnership that advances European cooperation in influenza vaccine effectiveness studies, funded by, amongst others the Innovative Medicines Initiative (IMI).  He lives with his wife and son in Amsterdam, the Netherlands.

Inhaltsangabe

1.The Interplay Between Microorganisms and the Immune System.- 2. Analysis of Immunogenicity Data.- 3. Vaccine Field Studies.- 4. Correlates of Protection.- 5. Analysis of Vaccine Safety Data.